Russia Publishes Coronavirus Vaccine Results, Weeks After Approval

Vaccine developers say it appears to be safe and prompted antibody response in all 40 people tested in the second phase. However, participants were only followed for 42 days, the study sample was small and there was no placebo or control vaccine used